Effectiveness Transfer Energy Capacitive and Resistive Therapy in Patients With Carpal Tunnel Syndrome

NCT06451094 | Completed

• 1 other identifier: E2-23-3833
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

Objective: The aim of this study was to evaluate the effect of Transfer Energy Capacitive and Resistive (TECAR) therapy on pain, symptom severity and function in patients diagnosed with carpal tunnel syndrome (CTS) based on clinical and electromyography (EMG) findings and to compare it with ultrasound therapy (US). Methods: A total of 42 patients aged between 18 and 65 years, were randomly divided into two groups; group 1, US therapy 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions, group 2 TECAR therapy 5 min capacitive (CAP) and 10 min resistive (RES), 3 days a week for 2 weeks, for a total of 6 sessions. Both groups received paraffin therapy and wrist orthosis. All Patients were evaluated using the Visual Analog Scale (VAS) for pain and paresthesia levels, the Boston Carpal Tunnel Questionnaire (BCTQ) for symptom severity and functional levels. Additionally, median nerve CSA was measured by ultrasound, at the baseline, post-treatment, first and third months.

Conditions

Carpal Tunnel Syndrome; Energy Transfer Capacitative and Resistive Therapy

Keywords

Carpal tunnel syndrome; TECAR therapy; median nerve CSA

Outcome Measures

Primary Outcomes (2)

• Visual Analog Scale (VAS)

  0 min , 10 is maximum pain score

  baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month

• Boston Carpal Tunnel Questionnaire (BCTQ)

  symptom severity on functional tasks (Symptom Severity Scale), involving 11 items, and the other one on function status properly (Functional Status Scale), involving 8 items. Both subscales of BCTQ are scored between 1 and 5, and higher scores illustrate a greater degree of disability.

  baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month

Secondary Outcomes (1)

• Median nerve cross-sectional area (CSA) measurement

  baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month

Study Arms (2)

US therapy, paraffin therapy

EXPERIMENTAL

Group 1, US therapy to the palmar region of the wrist, 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions and Paraffin therapy to the wrist area by dipping the hand 3 times into a paraffin bath and removing it, covering the entire wrist with paraffin, and waiting for 15 min (2 weeks, 5 times a week, for a total of 10 sessions).

Device: US therapy

TECAR therapy, paraffin therapy

EXPERIMENTAL

Group 2, TECAR therapy to the palmar region of the wrist, 5 min capacitive (CAP) and 10 min resistive (RES), 3 days a week for 2 weeks, for a total of 6 sessions and Paraffin therapy to the wrist area by dipping the hand 3 times into a paraffin bath and removing it, covering the entire wrist with paraffin, and waiting for 15 min (2 weeks, 5 times a week, for a total of 10 sessions).

Device: TECAR

Interventions

US therapy DEVICE

3 MHz probe with a BTL brand device at a dose of 1.5 watts/cm2 for 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions.

US therapy, paraffin therapy

TECAR DEVICE

Transfer Energy Capacitative and Resistive Therapy

TECAR therapy, paraffin therapy

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age and over
• had pain and numbness in their hands for more than 3 months were evaluated
• Patients diagnosed with mild and moderate CTS by EMG

You may not qualify if:

• metabolic, rheumatic, or neurological diseases that could affect the median nerve cross-sectional area (CSA)
• patients who had previously undergone surgery on the wrist,
• oncology patients,
• pregnancy,
• pacemakers.

Sponsors & Collaborators

• Ankara City Hospital Bilkent: lead

Study Sites (1)

Özge TEZEN

Ankara, Turkey (Türkiye)

Location

Related Publications (1)

• Tezen O, Ata AM, Uzun O, Cakir F, Yasar E. Comparison of the effectiveness of ultrasound and transfer energy capacitive and resistive (TECAR) therapy in patients with carpal tunnel syndrome. Lasers Med Sci. 2025 Mar 19;40(1):147. doi: 10.1007/s10103-025-04412-z.

  PMID: 40106005 DERIVED

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Nerve Compression Syndromes; Cumulative Trauma Disorders; Sprains and Strains; Wounds and Injuries

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 3, 2024
• First Posted: June 10, 2024
• Study Start: May 15, 2023
• Primary Completion: November 15, 2023
• Study Completion: February 15, 2024
• Last Updated: June 11, 2024

Record last verified: 2024-06

Locations

TU (1)